Literature DB >> 8505499

Reactive lymphoid hyperplasia of the liver.

H Isobe1, S Sakamoto, H Sakai, A Masumoto, T Sonoda, E Adachi, H Nawata.   

Abstract

A patient with reactive lymphoid hyperplasia of the liver was symptom free and had no underlying disease except for diabetes mellitus. The hepatic tumor was found by ultrasound examination at routine checkup. The preoperative diagnosis of the tumor was unsuccessful despite various radiological examinations. Histological examination of the resected tumor showed that it was composed of benign-appearing lymphocytic proliferations forming lymphoid follicles that included numerous germinal centers. The germinal center was mainly composed of B-cell marker, L26-positive lymphocytes, but a few T cells were also found. Lymphocytes surrounding germinal centers were mainly T-cell marker, UCHL1-positive T-cells, and a small number of B cells. The B cells in the lymphoid follicles were stained for both kappa and lambda light chains at equal frequency, indicating polyclonal and benign nature. A diagnosis of reactive lymphoid hyperplasia of the liver seems justified.

Entities:  

Mesh:

Year:  1993        PMID: 8505499     DOI: 10.1097/00004836-199304000-00017

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

1.  Nodular lymphoid lesion of the liver with simultaneous focal nodular hyperplasia and hemangioma: discrimination from primary hepatic MALT-type non-Hodgkin's lymphoma.

Authors:  Klaus Willenbrock; Susanne Kriener; Sabine Oeschger; Martin-Leo Hansmann
Journal:  Virchows Arch       Date:  2005-12-06       Impact factor: 4.064

Review 2.  Reactive lymphoid hyperplasia of the liver in a patient with multiple carcinomas: a case report and brief review.

Authors:  K Sato; Y Ueda; M Yokoi; K Hayashi; T Kosaka; S Katsuda
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

3.  Hepatic reactive lymphoid hyperplasia in a patient with primary biliary cirrhosis.

Authors:  Mitsuaki Ishida; Tamio Nakahara; Yousuke Mochizuki; Tomoyuki Tsujikawa; Akira Andoh; Yasuharu Saito; Hiroshi Yamamoto; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Hepatol       Date:  2010-10-27

Review 4.  Reactive lymphoid hyperplasia of the liver: a case report and review of literature.

Authors:  Takuro Machida; Toshiyuki Takahashi; Tomoo Itoh; Michiaki Hirayama; Takayuki Morita; Shoichi Horita
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

5.  Segmentectomy for reactive lymphoid hyperplasia of the liver: Report of a case.

Authors:  Naoki Maehara; Kazuo Chijiiwa; Ichiro Makino; Jiro Ohuchida; Masahiro Kai; Kazuhiro Kondo; Sayaka Moriguchi; Kousuke Marutsuka; Yujiro Asada
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 6.  Pseudolymphoma of the liver associated with primary biliary cirrhosis: a case report and review of literature.

Authors:  Toshihide Okada; Hiroshi Mibayashi; Kenkei Hasatani; Yoshiaki Hayashi; Shigetsugu Tsuji; Yoshibumi Kaneko; Masashi Yoshimitsu; Takashi Tani; Yoh Zen; Masakazu Yamagishi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

7.  Reactive lymphoid hyperplasia of the liver: a clinicopathological study of 7 cases.

Authors:  Lei Yuan; Youlei Zhang; Yi Wang; Wenming Cong; Mengchao Wu
Journal:  HPB Surg       Date:  2012-07-30

8.  A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis.

Authors:  Hiroki Kanno; Hisamune Sakai; Toru Hisaka; Satoki Kojima; Ryuta Midorikawa; Shogo Fukutomi; Yoriko Nomura; Yuichi Goto; Toshihiro Sato; Munehiro Yoshitomi; Ryuichi Kawahara; Koji Okuda
Journal:  Surg Case Rep       Date:  2020-05-04

9.  Reactive lymphoid hyperplasia of the liver.

Authors:  Woo Sung Moon; Keum Ha Choi
Journal:  Clin Mol Hepatol       Date:  2013-03

Review 10.  Histiocyte-rich reactive lymphoid hyperplasia of the liver: unusual morphologic features.

Authors:  Ho Sung Park; Kyu Yun Jang; Young Kon Kim; Baik Hwan Cho; Woo Sung Moon
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.